When Anxiety Attacks: Treating Hyperventilation and Panic

Physician and Sportsmedicine

Volumn 24, Issue 12, 1996, Pages 54-65

  Rubin, Aaron ^a   Chassay, C Mark ^b   Howe, Warren B ^c  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c WESTERN WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ANXIETY NEUROSIS; ATHLETE; CASE REPORT; DRUG CHOICE; HUMAN; HYPERVENTILATION; MALE; PANIC; REVIEW; SPORTS MEDICINE;

EID: 10544243360     PISSN: 00913847     EISSN: 23263660     Source Type: Journal    
DOI: 10.3810/psm.1996.12.1273     Document Type: Article

References (14)

1. Garssen B, Buikhuisen M, van Dyck R: Hyperventilation and panic attacks. Am J Psych 1996; 153 (4): 513 – 518
2. Stauffer JL: Lung, in Tierney LM, Jr, McPhee SJ, Papadakis MA: Current Medical Diagnosis and Treatment, ed 34. East Norwalk, CT, Appleton and Lange, 1995
3. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, DC, American Psychiatric Association, 1996
4. Katon W: Panic Disorder in the Medical Setting. Rockville, MD, National Institute of Mental Health (DHHS Publication No. [ADM] 89–1629), 1989
5. Mattick RP, Andrews G, Hadzi-Pavlovic D, et al: Treatment of panic and agoraphobia: an integrative review. J Nerv Ment Dis 1990; 178 (9): 567 – 76
6. Weinstein RS: Panic disorder. Am Fam Physician 1995; 52 (7): 2055 – 2063
7. Fuentes RJ, Rosenberg JM, Davis A (eds): Athletic Drug Reference '96. Durham, NC, Glaxo: Clean Data, 1996
8. Herman GL: Treatments for panic disorder. J Clin Psych 1992; 53 (Mar suppl): 14 – 19
9. Garssen B, de Ruiter C, van Dyck R: Breathing retraining: a rational placebo? Clin Psychol Rev 1992; 12 (2): 141 – 153
10. Bigger JT, Kantor SJ, Glassman AH, et al: Cardiovascular effects of tricyclic antidepressant drugs, in Lipton MA, DiMascio A, Killam KF (eds): Psychopharmacology: A Generation of Progress. New York City, Raven Press, 1978
11. Sheehan DV: Delineation of anxiety and phobic disorders responsive to monoamine oxidase inhibitors: implications for classification. J Clin Psych 1984; 45 (7 pt 2): 29 – 36
12. Tollefson GD: Monoamine oxidase inhibitors: a review. J Clin Psych 1983; 44 (8): 280 – 288
13. Ravaris CL, Friedman MJ, Hauri PJ, et al: A controlled study of alprazolam and propranolol in panic-disordered and agoraphobic outpatients. J Clin Psychopharmacol 1991; 11 (6): 344 – 350
14. Pecknold JC, Swinson RP Kuch K, et al: Alprazolam in panic disorder and agoraphobia: results from a multicenter trial: III: discontinuation effects. Arch Gen Psych 1988; 45 (5): 429 – 436